A meta-analysis has revealed that the XRCC3 gene rs861539 polymorphism also increases the risk of developing hepatocellular carcinoma, as well as head and neck, bladder, and breast cancer [11, 32, 33, 60–62]. Here, XRCC3 is linked to breast carcinoma.